HAEMONETICS CORP : Regulation FD Disclosure (form 8-K)

Item 7.01 Regulation FD Disclosure.

On June 29, 2020, Haemonetics Corporation (the "Company") completed the sale to GVS S.p.A. ("GVS") of its Fajardo, Puerto Rico manufacturing operations for approximately $15.5 million in cash, which includes the transfer of approximately $7.5 million in positive net working capital to GVS as of closing, and simultaneously entered into a long-term supply and development agreement and transition services agreement with GVS, in each case consistent with the terms previously disclosed in the Company's Current Report on Form 8-K dated June 11, 2020.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses